Table 5.
Optimal and suboptimal adherence (stopped and missed) vs factors of adherence
| Variables | Response | Stopped doses n (%) | Missed doses n (%) | Optimal adherence n (%) | Total n (%) | Chi-square test P (significant <0.05) |
|---|---|---|---|---|---|---|
| Pre-treatment | Received | 18 (28) | 38 (59) | 8 (13) | 64 (46) | 0.03 |
| counselling | Not received | 21 (28) | 53 (71) | 1 (1) | 79 (54) | |
| Total | 39 (28) | 91 (65) | 9 (6) | 139 (100) | ||
| Know the name of current ART | Yes | 21 (20) | 74 (71) | 9 (9) | 104 (75) | 0.00 |
| No | 18 (51) | 17 (49) | 0 (0) | 35 (25) | ||
| Total | 39 (28) | 91 (65) | 9 (6) | 139 (100) | ||
| Received counselling on the importance of lifelong treatment | Yes | 4 (7) | 45 (83) | 5 (9) | 54 (39) | 0.00 |
| No | 35 (41) | 46 (54) | 4 (5) | 85 (61) | ||
| Total | 39 (28) | 91 (65) | 9 (6) | 139 (100) | ||
| Type of failure | Virologic failure | 1 (11) | 6 (67) | 2 (22) | 9 (6) | 0.00 |
| Immunological failure | 14 (19) | 53 (73) | 6 (8) | 73 (53) | ||
| Clinical failure | 24 (42) | 32 (56) | 1 (2) | 57 (41) | ||
| Total | 39 (28) | 91 (65) | 9 (6) | 139 (100) |